STAT Plus: Biogen strikes $1 billion deal with Denali to advance Parkinson’s drug based on approach that was nearly abandoned
Biogen said Thursday it will pay more than $1 billion to the biotech firm Denali…
Category: biotehnology
Biogen said Thursday it will pay more than $1 billion to the biotech firm Denali…